PXAI Audio Feed
24/04 21:45 statnews.com

STAT+: FDA to speed up review of 3 psychedelics as mental health treatments

FDAPHARMARESEARCHSTAT+BIOTECHNOLOGYDRUG DEVELOPMENT
24/04 20:50 statnews.com

STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B

THE READOUT LOUDPHARMACEUTICAL INDUSTRYELI LILLYBIOTECHPOLITICSVENTURE CAPITAL
24/04 20:04 wired.com

Designer Baby Companies Are in Turmoil

GENETICSGENE EDITINGPOLITICSSCIENCE / BIOTECHBIOTECHSTARTUPS
24/04 18:53 statnews.com

STAT+: Up and Down the Ladder: The latest comings and goings

JOBSEARTHQUAKEPOLITICSBIOTECHNOLOGYPHARMALOTSTAT+
24/04 00:34 statnews.com

A CAR-T biotech’s dramatic turnaround, and drugmakers’ tactics to drive more scripts

BIOTECHNOLOGYTELEHEALTHOBESITYPOLITICSCANCERMEDICARE
23/04 23:05 statnews.com

STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead

BIOTECHBUSINESSBREAKING NEWSPOLICYBIOTECHNOLOGYDRUG PRICES
23/04 19:55 statnews.com

STAT+: Legislatures in Colorado and Virginia resist moves to constrain drug affordability boards

STAT+PHARMALOTPOLITICSBIOTECHNOLOGYDRUG PRICINGPHARMACEUTICALS
23/04 19:14 statnews.com

STAT+: Sanofi research priorities in flux as new CEO logs in

RESEARCHBIOTECHPHARMABUSINESSBIOTECHNOLOGYPOLITICS
23/04 13:30 statnews.com

STAT+: Can Erasca be biotech’s next big thing? We’ll see

STAT+BIOTECHNOLOGYPOLITICSADAM'S TAKEADAM'S BIOTECH SCORECARDBIOTECH
23/04 13:30 statnews.com

STAT+: Can Erasca be biotech’s next big thing? We’ll see

STAT+BIOTECHNOLOGYPOLITICSADAM'S TAKEADAM'S BIOTECH SCORECARDBIOTECH
Comments
Loading...
0